BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway
Authors:
Open Access
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 208, 284-294
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81772484)
- National Basic Research Program of China (2016YFC0905500, 2016YFC0905501)
This publication has 28 references indexed in Scilit:
- Pharmacological modulation of beta‐catenin and its applications in cancer therapyJournal of Cellular and Molecular Medicine, 2013
- Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old IdeaJournal of Clinical Oncology, 2013
- Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt SignalingScience Translational Medicine, 2012
- Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer CellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progressionBreast Cancer Research, 2011
- Bcl9/Bcl9l Are Critical for Wnt-Mediated Regulation of Stem Cell Traits in Colon Epithelium and AdenocarcinomasCancer Research, 2010
- BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer CellsCancer Research, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- WNT Signaling Pathway and Stem Cell Signaling NetworkClinical Cancer Research, 2007
- Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-CateninCells Tissues Organs, 2005